— Know what they know.
Not Investment Advice

REPL NASDAQ

Replimune Group, Inc.
1W: +5.7% 1M: -18.2% 3M: +13.9% YTD: +46.9% 1Y: +210.4% 3Y: -21.3% 5Y: -59.5%
$13.07
-0.38 (-2.83%)
 
Weekly Expected Move ±6.5%
$11 $12 $13 $14 $15
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $1.1B mcap · 79M float · 5.95% daily turnover · Short 56% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-314M
Net Income
-26.9% YoY
$-285M
Free Cash Flow
-43.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-107.9%
ROA-71.0%
ROIC-2853.5%

Valuation

P/E-4.1
P/B12.0
EV/EBITDA-1.8

Leverage

Debt/Equity0.67
Current Ratio4.79
Interest Cov.-35.5x

Quality Scores

Piotroski F1/9
Altman Z-5.08
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms